Skip to main content
Clinical Trials/NCT04412525
NCT04412525CompletedNot Applicable

Comparative Study 27G Vitrectomy vs Larger Gauge Surgery

Universitaire Ziekenhuizen KU Leuven2 sites in 1 country50 target enrollmentStarted: June 5, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
2
Primary Endpoint
changes in post-operative outcome of pain

Study Overview

Brief Summary

Two-arm, mono-center, prospective, interventional comparative case study to compare postoperative recovery between the 27G and larger gauge surgical approach.

Detailed Description

A prospective randomized comparison of postoperative recovery between 27-gauge and larger gauge surgical approaches to evaluate efficiencies and postoperative outcomes of the surgical gauges. Fifty patients who were scheduled to undergo pars plana vitrectomy (PPV) for floaters or macular surgery were treated with either 27-gauge or 23-gauge techniques and assessed for efficiency of the procedures as well as a variety of postop indicators of pain and inflammation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients aged over 18
  • No prior vitrectomy surgery in the study eye (for the same eye)
  • No prior inclusion in this trial
  • Scheduled for vitrectomy for floater removal or macular surgery (including macular holes) without endotamponades such as PFCL, Gas, Silicone oil). (Air tamponade is allowed )

Exclusion Criteria

  • • Patients with serious heart, lung, liver, or kidney dysfunction
  • Patients with proliferative diabetic retinopathy, endophthalmitis, uveitis, eyes with refraction >+5D or exceeding -8D , or other eye disease that impacts the outcome of vitrectomy surgery
  • Patients with HIV
  • Patients with history of drug abuse or alcoholism
  • Patients participating in other drug or medical device clinical trials before screening for this trial

Outcomes

Primary Outcomes

changes in post-operative outcome of pain

Time Frame: day 1 postoperative

by assessing the amount of pain on a visual analogue scale (score 0-9)

changes in post-operative outcome of redness

Time Frame: day 1 postoperative

scoring the amount of redness on a scale 0-4 through eye photos

changes in post-operative outcome in grading of anterior chamber cells

Time Frame: day 1 postoperative

clinical assessment by slit lamp examination (Tyndall 0-3 and Cells 0-3)

Secondary Outcomes

  • visual acuity(day 1 postoperative)
  • pain-assessment(1 week postoperative)
  • intra-ocular pressure(day 1 postoperative)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials